DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Molbio Diagnostics Limited — Analyst/Investor Meet Para A-XBRL

NSE 3 hrs ago·2 Nov 2026, 2:18 pm

Molbio Diagnostics

Molbio Diagnostics Limited has informed stock exchanges that it will host an investor or analyst meeting. This announcement is a routine corporate disclosure, indicating the company intends to share its business outlook with the investment community. Such meetings often provide insights into the company's future strategy, product pipeline, or financial performance targets. For investors, this is a standard update that signals the company is open to dialogue with the market.

The significance of this meeting lies in the information it may reveal. While the company has not disclosed specific details yet, investors often look for updates on growth plans, especially in the competitive diagnostics sector. Monitoring the company's subsequent press releases or transcripts from the event will be crucial for understanding management's tone and future direction. Keep an eye on any guidance provided regarding revenue or product launches.